Summary. The presence of a fecundity gene (F) 
Introduction
The Booroola Merino breed of sheep carries a major fecundity gene(s) (F) which influences the ovulation rate (Bindon, 1984) . Ewes homozygous for the F gene (i.e. FF animals) produce >5 ovulations, compared with 3-4 in heterozygous (F + ) ewes and 1 or 2 in the non-F gene carriers (i.e. ++ animals) (Davis et al, 1982) . Follicles in FF animals develop the ability to synthesize oestradiol and reach ovulatory maturity at a smaller diameter than in ++ animals. However, the number of granulosa cells per oestrogenic follicle is significantly less in the FF compared with that in follicles from F+ ewes, which in turn, is less than that in ++ ewes so that the overall steroid output from both ovaries is similar in all 3 genotypes (McNatty et al, 1986) .
Booroola Merinos with the F gene have been shown to have higher pituitary contents of immunoreactive follicle-stimulating hormone (FSH) than ++ ewes (Robertson et al, 1984; Bindon, 1984; Bindon et al, 1985; McNatty et al, 1987) . Moreover, McNatty et al. (1987) 
]GnRH, somatostatin, serotonin, melatonin, substance P, met-and leu-enkephahn, noradrenaline, l-and D-glutamic acid, PGE-2, GABA, dopamine, angiotensin I and II, TRH, LH, FSH, relaxin and oxytocin (data supplied by Dr Ramirez). However, antiserum CCR11B73 does appear capable of binding to larger, prohormone GnRH molecules in the human brain (King et al, 1985) . The final antiserum dilution was 1:50 000, in 0-02 M-phosphate buffered saline (PBS), pH 7-5, containing 01% sodium azide, 005 M-EDTA and 1:400 normal rabbit serum. At this antiserum dilution the %B0 was 36% and the non-specific binding was 3-5%. Synthetic GnRH (Peninsula Laboratories Inc., Belmont, CA 94002, U.S.A.) was used as the assay standard and iodinated according to Nett & Adams (1977) . Standards (0-200 pg/tube) and lyophilized samples were diluted in 0-02M-PBS, pH7-5, containing 01% gelatin, 1 mM-bacitracin and 01% sodium azide. 
Results
When serial dilutions of ME extracts from FF and +-1-animals were assayed, the slopes of the dilution lines for FF and ++ ewes and the standard GnRH assay curve after logit-log transform¬ ation were -0-531 ± 0105 (s.d.; 6 dilutions; r = 0-91), -0-588 + 0083 (s.d.; 6 dilutions; r = 0-95) [16] 13 [16] 2-5 (1-5-21)
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[5] 0-08, 12-3 ± 1-3, 18-7 ± 1-4, 28-0 ± 2-2 and 51-5 ± 9-8pg/tube and for FF ewes (« = 8) they were 3-2 ± 10, 81 ± 0-8, 120 + 1-0, 22-9 + 1-7 and 52-5 + 5-3 pg/tube. These results indicate that the extracts contained insignificant GnRH-directed peptidase activity. (Lehman et al, 1986) . Low or insignificant GnRH immunoactivity was found in extracts of cerebral cortex, pineal and pituitary gland. The distribution of GnRH immunoactivity obtained was similar to that obtained previously in sheep, using antisera capable of detecting prohormonal GnRH (Millar et al, 1977; Gale, 1986 (McNatty et al, 1987) . These observations were compatible with increased GnRH release from the hypothalamus or changed pituitary receptor sensitivity in FF ewes. However, no significant F gene-specific differ¬ ences were observed in the GnRH tissue concentrations of Booroola ewes. In a simplistic model increased GnRH release might be expected to result in lower hypothalamic peptide concentrations in animals with the F gene. However, no conclusions can be drawn about the dynamics of GnRH synthesis and release from data presented here on tissue immunoactivity. We conclude that the changed pituitary sensitivity and increased gonadotrophin release observed in F gene carriers is unlikely to be attributed to changed GnRH concentrations in the hypothalamus.
GnRH is synthesized in a prohormonal form in nerve cell bodies found throughout the preoptic area, OVLT and septal nuclei of the sheep (Lehman et al, 1986 ). This precursor protein is then processed by a series of specific enzymes to produce at least two bioactive peptides, GnRH and GnRH-associated peptide (Seeburg & Adelman, 1984) . These processing events occur within the neurosecretory granules as the newly synthesized hormone proceeds from the ribosomes in the perikarya to nerve terminals in the OVLT and ME (Lehman et al, 1986) . Experiments using antisera directed to different parts of the GnRH decapeptide suggest that the prohormonal form is only detectable in the preoptic area and anterior hypothalamus, and that the majority of the GnRH immunoactivity measured in the ME is decapeptide (Millar et al, 1981; King et al, 1985; Gale, 1986) . The GnRH antiserum used in this study has been shown to stain immunocytochemically the endo¬ plasmic reticulum and neurosecretory granules in the perikarya of human anterior hypothalamus (King et al, 1985) . The immunoactivity determined with this antiserum should therefore be a measure of the total prohormonal plus decapeptide GnRH concentration in the tissue. However, Antiserum CRR11B73 requires the complete decapeptide sequence for binding to occur, and so decapeptide degradation products are unlikely to contribute to the immunoactivity measured with this antiserum (King et al, 1985) .
The distribution of GnRH in the hypothalamus changed in chronically ovariectomized animals, relative to that observed in intact ewes. In ovariectomized ewes the GnRH concentrations were about 2-fold higher in the ME and were reduced substantially in the preoptic area. A decrease in MBH and/or ME GnRH in response to long-term ovariectomy has been noted in the mouse (Briski et al, 1983) , rat (Culler et al, 1982) and sheep (Wheaton, 1979) . These results were initially interpreted as an increased release of the peptide under these conditions (Tytell et al, 1980; Millar et al, 1981; Shivers et al, 1983 ), but others have found an inhibition of GnRH release (Dluzen & Ramirez, 1985 , 1986 or a decrease in the amount of peptide available for release (Barnea & Cho, 1985) after gonadectomy. Polkowska et al. (1980) Millar et al. ( 1981 ) have shown that the concentrations of both the precursor and decapeptide forms of GnRH decrease markedly in 2-week castrated male rats and that the levels of both forms rise when intact rats are implanted with oestradiol. Drouva et al. ( 1986) , however, showed that levels of a C terminally-extended precursor form of GnRH increased in ovariectomized rats, concomitant with a decrease in the decapeptide. There is also some evidence that steroid hormones affect the activity of hypothalamic peptidases that degrade GnRH, possibly influencing the amount of decapeptide stored in the ME (Griffiths et al, 1975; Advis et al, 1983) . However, little is known about the effect of ovariectomy on the rate of prohormone processing events (Drouva et al, 1986) , especially in the sheep. It is possible that the increase in GnRH in the ME noted after ovariectomy is partly caused by a drop in GnRH peptidase activity in the nerve terminals (Griffiths et al, 1975) .
In conclusion these studies suggest that F-gene expression does not directly affect the tissue concentrations of GnRH in the hypothalamus of the Booroola ewe. However, altered GnRH release and turnover in F-gene carriers cannot be discounted.
